BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4220782)

  • 1. Differentiation of leukocytic fibrinolytic enzymes from plasmin by the use of plasmatic proteolytic inhibitors.
    Hermann G; Miescher PA
    Int Arch Allergy Appl Immunol; 1965; 27(6):346-54. PubMed ID: 4220782
    [No Abstract]   [Full Text] [Related]  

  • 2. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.
    Plow EF; Edgington TS
    J Clin Invest; 1975 Jul; 56(1):30-8. PubMed ID: 237938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular forms of plasmin and protease inhibitors in human fibrinolytic post-mortem plasma.
    Müllertz S
    Scand J Clin Lab Invest; 1972 Dec; 30(4):369-79. PubMed ID: 4118172
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunochemical demonstration of leucocyte proteases and inhibitors using fibrinagarelectrophoresis.
    Hermann G
    Prog Immunobiol Stand; 1970; 4():422-5. PubMed ID: 4249359
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukocytic fibrinolysis in myelomonocytic leukemia.
    Talarico L; Weintraub LR
    Cancer; 1977 Apr; 39(4):1618-24. PubMed ID: 265747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity].
    Fischer M
    Thromb Diath Haemorrh; 1970 Jun; 23(3):513-52. PubMed ID: 4247030
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative immunochemical characterization of products of plasmin and leukocyte protease cleavage of human fibrinogen.
    Plow EF; Edgington TS
    Thromb Res; 1978 Apr; 12(4):653-65. PubMed ID: 149393
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of fibrinolytic and proteolytic enzymes in subcellular fractions of human granulocytes.
    Prokopowicz J
    Thromb Diath Haemorrh; 1968 Mar; 19(1):84-93. PubMed ID: 5652242
    [No Abstract]   [Full Text] [Related]  

  • 9. Degradation of non cross-linked and cross-linked fibrin clots by plasmin, trypsin, chymotrypsin and Brinase.
    Gormsen J; Feddersen C
    Thromb Res; 1974 Aug; 5(2):125-39. PubMed ID: 4278050
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of streptococcal fibrinolysis; the dissimilarity of serum protease and trypsin as indicated by the separate specificities of their kinases, fibrinolysin and enterokinase.
    KAPLAN MH
    J Clin Invest; 1946 May; 25():331-6. PubMed ID: 20986038
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the proteolysis of fibrinogen and fibrin by Aspergillus ochraceus enzyme as compared to the action of plasmin.
    Teisseyre E; Latallo ZS; Kopeć M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):99-110. PubMed ID: 4134484
    [No Abstract]   [Full Text] [Related]  

  • 12. The plasminogen-plasmin system. 8. On the mechanism of chemical induction of fibrinolysis. Isolation of a latent plasminogen activator from human plasma.
    Tomikawa M; Abiko Y
    Thromb Diath Haemorrh; 1973 Feb; 29(1):50-62. PubMed ID: 4267738
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the fibrinolytic enzyme system in obesity.
    Bennett NB; Ogston CM; McAndrew GM; Ogston D
    J Clin Pathol; 1966 May; 19(3):241-3. PubMed ID: 4223015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on a proteolytic enzyme in human plasma; some factors controlling the rate of fibrinolysis.
    RATNOFF OD
    J Exp Med; 1948 Oct; 88(4):401-16. PubMed ID: 18884900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukocytes and fibrinolysis. II. Study of pathological leukocytes].
    Tatarsky I; Sinakos Z; Larrieu MJ; Bernard J
    Nouv Rev Fr Hematol; 1967; 7(1):95-107. PubMed ID: 4226638
    [No Abstract]   [Full Text] [Related]  

  • 16. The significance of plasma inhibitor(s) in the control of fibrinolytic (plasmin) activity in blood.
    Monkhouse FC; Milojevic S; Schmitt A
    Thromb Diath Haemorrh; 1972 Dec; 28(3):367-75. PubMed ID: 4265318
    [No Abstract]   [Full Text] [Related]  

  • 17. [PLASMATIC AND LEUKOCYTE FIBRINOLYSIS IN LEUKEMIAS].
    BOCCARDI V; GRASSO A
    Prog Med (Napoli); 1964 Jan; 20():18-22. PubMed ID: 14218747
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of gold sodium thiomalate on fibrinolysis.
    Moroz LA
    J Rheumatol Suppl; 1979; 5():149-53. PubMed ID: 158655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ELECTROPHORESIS AND IMMUNOELECTROPHORESIS OF SERUM PROTEINS. II. INFLUENCE OF PROTEOLYTIC ENZYMES].
    TENOROV JELINKOVA M; STUCHLIKOVA E
    Sb Lek; 1965 Mar; 67():72-9. PubMed ID: 14337895
    [No Abstract]   [Full Text] [Related]  

  • 20. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
    Aoki N; Moroi M; Matsuda M; Tachiya K
    J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.